CompagOs

CompagOs's mission is to assist oncologists in selecting the most effective treatment for bone cancer patients. By utilizing 3D bioprinting technology, we reconstruct the unique cancer conditions of patients' bones in a controlled laboratory environment, allowing us to evaluate different drug responses and identify personalized treatment plans. By surpassing the limitations of traditional animal and 2D models, we also envision our solution becoming a powerful tool for drug development, accurately reproducing human physiological conditions and driving innovation in this field. Our goal is to revolutionize cancer treatment by providing personalized solutions, improving patient outcomes, and advancing the field of oncology.